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Pseudorabies virus (PRV) is an alphaherpesvirus of swine. PRV has a large double-stranded DNA genome
and, as the latest investigations have revealed, a very complex transcriptome. Here, we present a large
RNA-Seq dataset, derived from both short- and long-read sequencing. The dataset contains 1.3 million 100
bp paired-end reads that were obtained from the Illumina random-primed libraries, as well as 10 million 50
bp single-end reads generated by the Illumina polyA-seq. The Paciﬁc Biosciences RSII non-ampliﬁed
method yielded 57,021 reads of inserts (ROIs) aligned to the viral genome, the ampliﬁed method resulted in
158,396 PRV-speciﬁc ROIs, while we obtained 12,555 ROIs using the Sequel platform. The Oxford
Nanopore’s MinION device generated 44,006 reads using their regular cDNA-sequencing method, whereas
29,832 and 120,394 reads were produced by using the direct RNA-sequencing and the Cap-selection
protocols, respectively. The raw reads were aligned to the PRV reference genome (KJ717942.1). Our
provided dataset can be used to compare different sequencing approaches, library preparation methods, as
well as for validation and testing bioinformatic pipelines.
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Background & Summary
Pseudorabies virus (PRV) is a causative agent of Aujeszky’s disease (AD)1 in pigs. PRV has a double-
stranded DNA genome with a size of approximately 143 kbp. PRV is often employed in laboratories to
study the molecular pathomechanism of the herpesviruses2. It is also a suitable tool as concerns gene and
tumour therapy3, as well as for mapping of neuronal circuits4–8. This virus has also been used as live
vaccines against AD9–11.
Here, we provide a large dataset derived from RNA-Seq experiments including different next-
generation sequencing (NGS) – and third-generation sequencing (3rdGS) techniques (Fig. 1). Our
aim with this study was to provide a dataset that can be used for comparison of the different sequencing
platforms and library preparation methods using PRV as a model organism. In addition, these data
are also applicable for identifying novel coding and non-coding transcripts, transcript isoforms,
splice variants of PRV, and for deﬁning full-length transcripts by using a combination of sequencing
platforms.
One of the most popular NGS platforms, the Illumina HiScanSQ was used to generate high quality
short-reads and extremely high coverage throughout the entire PRV genome. Random-primed cDNA
library was prepared from viral RNAs. Paired-end RNA sequencing was carried out to characterize novel
splice isoforms, as well as to obtain general information on the transcription activity of PRV12. PolyA-
sequencing was used to determine the 3′-ends of RNA molecules. With this technique, we were able to
detect alternative polyadenylation events in the PRV transcripts. Both libraries were run on a single ﬂow
cell resulting in 1.3 million 100 bp paired-end reads from the random hexamer-primed libraries, and 10
million 50 bp single-end reads from the poly(A)-enriched RNA-Seq, aligning to the viral reference13
(KJ717942.1).
Although the error rate of 3rdGS techniques is higher than those of NGS’s14, they are able to identify
novel full-length transcripts15–17 and are therefore more applicable for global transcriptome proﬁling and
RNA isoform detection compared to short-read techniques.
The Real-Time Sequencer II (RSII) and the Sequel 3rdGS platforms from Paciﬁc Biosciences (PacBio)
and the Oxford Nanopore Technologies (ONT) MinION 3rdGS device were used to characterize the
static18,19 and dynamic20 PRV transcriptome. These sequencing techniques, with the library preparation
methods [e.g. non-ampliﬁed SMRT method and ampliﬁed, Iso-seq protocol from the PacBio; full-length
cDNA-sequencing, direct RNA-sequencing, and cDNA-sequencing on 5′Cap-selected samples from
ONT, (Fig. 1,2)] used in these studies made it possible to identify several hundreds of novel transcript
isoforms (including 3′- and 5′ UTR variants, and splice isoforms), as well as dozens of protein-coding and
non-coding RNAs and numerous complex transcripts of PRV.
Seventy-one SMRT Cells were run on RSII system. P5-C3 chemistry and 180-minute data collection
mode was used for the non-ampliﬁed samples, while P6-C4 enzymes were applied and 240 or 360 min
movies were recorded for the ampliﬁed samples. cDNAs were sequenced on a single Sequel SMRT Cell
with P6-C4 reagents; 10 h run-time was applied. Altogether seven MinION ﬂow cells were used for the
different ONT approaches.
The raw sequencing reads were mapped to the above-mentioned reference genome. Sequencing on the
RSII platform resulted in 215,417 reads of inserts (ROIs), while the utilized nanopore sequencing
methods generated altogether 194,232 PRV speciﬁc reads (Table 1). The average read lengths aligning to
the PRV genome were 1,326 bp for PacBio RSII, 1,763 bp for the Sequel and 827 bp for ONT. It should be
noted that the library preparation and size-selection methods resulted in different samples in length
(Table 2).
Figure 1. Data ﬂow diagram shows the detailed overview of the study design.
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This dataset can help explore the advantages and disadvantages associated with each sequencing
method used in this work. This approach can be used for the analysis of multiple features of the
sequencing platforms, including read length, base-calling error rate, coverage and mappability. The
application of the various sequencing techniques can be evaluated by the analysis of the identiﬁed
transcript isoforms, and the quantiﬁcation of the transcriptome comparing the performance of Illumina,
PacBio and ONT. This dataset is also useful for the analysis of the transcriptome complexity of PRV. Our
data include a sub-dataset which can be used for the transcriptome analysis of PRV during an infection
period including six different time-points.
Here we provide a detailed overview of the library preparation techniques and a description of the data
(Table 3, Figs. 1 and 2).
Methods
Schematic overviews of the methodological workﬂow are shown in the ﬂowchart of Figs. 1 and 2. The
applied reagents and utilized approaches are listed in Table 4.
Cells, viruses and infection conditions
Immortalized porcine kidney-15 (PK-15; ATCC® CCL-33™) cells were used for the propagation
of pseudorabies virus strain Kaplan (PRV-Ka) at 37 °C and 5% CO2 in Dulbecco’s modiﬁed
Eagle medium (DMEM, Gibco Invitrogen) supplemented with 5% foetal bovine serum (FBS; Gibco
Invitrogen). The virus stock was originally obtained from the Kaplan Lab (Department of Microbiology,
Vanderbilt University School of Medicine, Nashville, Tennessee)21, but Vanderbilt University received
it from Dr. Richard F. Haff in a suspension of infected mouse brain22. Gentamycin (80 μg/ml) was
also added to the cell culture medium. The virus stock was prepared as follows: the medium was
removed from the rapidly-growing semi-conﬂuent PK-15 cells then it was infected with the Kaplan
strain of PRV (a multiplicity of infection of 0.1 plaque-forming unit (pfu)/cell). Infected cells
were incubated until complete cytopathic effect was observed. Samples were taken through three times
freeze-thaw cycles, followed by centrifugation at 10,000 g for 15 min. The titre of the virus stock
was determined in PK-15 cells. For all experiments, cells were infected with a high MOI (10 pfu/cell)
and incubated for 1 h, followed by removal of the virus suspension and washing of the cells with
phosphate-buffered saline (PBS). The number of cells in a culture ﬂask was 5 × 106. After the addition
of new medium to the cells, they were incubated for 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 or 24 h pi
and they both were mixed for Illumina sequencing (Table 3). One, 2, 4, 6, 8 and 12 h of incubation
were used for the non-ampliﬁed PacBio sequencing, while the 1, 2, 4, 6 and 8 h pi samples were utilized
for the PacBio ampliﬁed, Iso-Seq protocol. Samples from different time points were individually
sequenced on the RSII, but they were also mixed for PacBio sequencing (Table 3). The incubation
time was 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 18 and 24 h and a mixture from them was used for all types of
ONT sequencing (Table 3).
RNA puriﬁcation
Isolation of total RNAs The NucleoSpin
®
RNA II kit (Macherey-Nagel) was used to isolate RNA from
samples for Illumina sequencing, while the new version, the NucleoSpin
®
RNA kit (Macherey-Nagel) was
used for all the other samples, as was described earlier12,18,20. Brieﬂy, cells were collected by centrifugation
and lysed by incubation in a solution containing large amounts of chaotropic ions. This buffer inactivates
the RNase. Nucleic acid molecules bind to the silica membrane. All samples were handled with DNase I
solution (provided by the kit) to remove residual DNA contaminations. Total RNAs were eluted from the
membrane in RNase-free water. To eliminate the potential remaining DNA contamination, samples were
Figure 2. Data ﬂow diagram shows the detailed overview of the wet lab experiments and bioinformatics
pipelines.
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treated by Ambion® TURBO DNA-free™ Kit. The ﬁnal concentrations of the RNA samples
were determined by Qubit®. 2.0 Fluorometer using Qubit RNA BR Assay Kit (Life Technologies).
RNA quality was assessed with the Agilent Bioanalyzer 2100 and RIN scores above 9.6 were used
for cDNA production. RNA samples were stored at −80 °C until further use. Samples were made as
follows: The Illumina oligodT- and random-primed sequencing reactions were carried out from the
same RNA mixture. The libraries for the kinetic analysis and for the mixed sequencing using PacBio RSII
(non-ampliﬁed method) were all prepared from different cell culture ﬂasks (containing 5 × 106 cells/
ﬂask), but the same virus stock was used for these infections. For the ampliﬁed RSII sequencing,
samples were prepared from separate ﬂasks (each containing 5 × 106 cells and infected with the same
Samplea Number of PRV readsb Number of mapped readsc
MinION-Cap-selected 120394 131223
MinION-cDNA 44006 47363
MinION-RNA 29832 30667
Sequel 12555 13481
RSII-PolyA-ampliﬁed-1h 6956 6956
RSII-PolyA-ampliﬁed-4h 22958 22958
RSII-PolyA-ampliﬁed-8h 46147 46147
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8h-Bluepippin 0.8kb-5kb+ 1077 1077
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8h-Bluepippin 0.8-2kb 7728 7728
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8h-Bluepippin 2-3kb 6131 6131
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8h-Bluepippin 3-5kb 3705 3705
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8h-Bluepippin 5kb+ 4061 4061
RSII-PolyA-ampliﬁed-1, 4, 8h,-Manual Gel 1-2kb 3822 3822
RSII-PolyA-ampliﬁed-1h-Manual Gel 3kb+ 3110 3110
RSII-PolyA-ampliﬁed-1h-Manual Gel 2-3kb 483 510
RSII-PolyA-ampliﬁed-4h-Manual Gel 3kb+ 2645 2928
RSII-PolyA-ampliﬁed-4h-Manual Gel 2-3kb 14348 15708
RSII-PolyA-ampliﬁed-8h-Manual Gel 3kb+ 3443 3765
RSII-PolyA-ampliﬁed-8h-Manual Gel 2-3kb 1608 1765
RSII-random-ampliﬁed-1, 2, 4, 6, 8h 1804 1953
RSII-random-ampliﬁed-1h 2327 2485
RSII-random-ampliﬁed-4h 7202 7629
RSII-random-ampliﬁed-8h 11452 12259
RSII-random-ampliﬁed-1, 4, 8h,-Manual Gel 3kb+ 1778 1855
RSII-random-ampliﬁed-1, 4, 8h,-Manual Gel 1-2kb 2218 2425
RSII-random-ampliﬁed-1, 4, 8h,-Manual Gel 2-3kb 3393 3627
RSII-PolyA-non ampliﬁed-1h (1st) 74 81
RSII-PolyA-non ampliﬁed-1h (2nd) 7392 7440
RSII-PolyA-non ampliﬁed-2h (1st) 124 125
RSII-PolyA-non ampliﬁed-2h (2nd) 12944 13121
RSII-PolyA-non ampliﬁed-4h (1st) 1369 1574
RSII-PolyA-non ampliﬁed-4h (2nd) 1023 1054
RSII-PolyA-non ampliﬁed-6h (1st) 2144 2269
RSII-PolyA-non ampliﬁed-6h (2nd) 10151 10231
RSII-PolyA-non ampliﬁed-8h (1st) 219 237
RSII-PolyA-non ampliﬁed-8h (2nd) 7915 8015
RSII-PolyA-non ampliﬁed-12h (1st) 935 1002
RSII-PolyA-non ampliﬁed-12h (2nd) 12731 12864
Table 1. Summary of the obtained read counts from long-read sequencing aligned to the PRV
genome. aType of the samples. bTotal number of PRV-speciﬁc reads. cTotal number of reads mapped to the
PRV genome. (There is an approximately 15 kb-long inverted repeat sequence region in the PRV genome,
therefore those reads which map to this location occur in duplicate in row c).
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virus stock). The Sequel and the various MinION libraries have been prepared using the same RNA
mixture.
Ribosomal RNA depletion For the Illumina sequencing and for the PacBio random-primed
sequencing, the total RNA samples were depleted from rRNA using the Epicentre Ribo-Zero™ Magnetic
Kit H/M/R (Illumina).
Selection of PolyA(+) RNA For the PacBio and MinION polyA sequencing, the polyA(+) fraction of
the RNA samples were isolated using the Qiagen Oligotex mRNA Mini Kit, following the “Spin
Columns” protocol.
PolyA puriﬁed and rRNA depleted RNA samples were quantiﬁed through use of the Qubit RNA HS
Assay Kit (Life Technologies) and then subjected to cDNA synthesis according to the downstream
applications.
Samplea Avr. Read Lengthb Avr. Read Length SDc
MinION-Cap-selected 810.00 519.07
MinION-cDNA 786.00 936.86
MinION-RNA 909.00 664.56
Sequel 1763.00 745.01
RSII-PolyA-ampliﬁed-1 h 1333.00 989.17
RSII-PolyA-ampliﬁed-4 h 1193.00 977.50
RSII-PolyA-ampliﬁed- 8h 1365.00 874.74
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8 h-Bluepippin 0.8kb-5 kb+ 1555.00 938.80
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8 h-Bluepippin 0.8-2 kb 1362.00 381.91
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8 h-Bluepippin 2-3 kb 1300.00 474.58
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8 h-Bluepippin 3-5 kb 1048.00 489.94
RSII-PolyA-ampliﬁed-1, 2, 4, 6, 8 h-Bluepippin 5 kb+ 1268.00 484.31
RSII-PolyA-ampliﬁed-1, 4, 8 h,-Manual Gel 1-2 kb 1251.00 532.61
RSII-PolyA-ampliﬁed-1 h-Manual Gel 3kb+ 1805.00 1875.46
RSII-PolyA-ampliﬁed-1 h-Manual Gel 2-3 kb 1661.00 852.13
RSII-PolyA-ampliﬁed-4 h-Manual Gel 3kb+ 2054.00 3654.40
RSII-PolyA-ampliﬁed-4 h-Manual Gel 2-3kb 1644.00 1874.46
RSII-PolyA-ampliﬁed-8 h-Manual Gel 3 kb+ 1660.00 358.94
RSII-PolyA-ampliﬁed-8 h-Manual Gel 2-3 kb 1701.00 1162.41
RSII-random-ampliﬁed-1, 2, 4, 6, 8 h 772.00 382.48
RSII-random-ampliﬁed-1 h 1121.00 438.93
RSII-random-ampliﬁed-4 h 1109.00 557.74
RSII-random-ampliﬁed-8 h 1105.00 468.34
RSII-random-ampliﬁed-1, 4, 8 h,-Manual Gel 3 kb+ 1726.00 2107.78
RSII-random-ampliﬁed-1, 4, 8 h,-Manual Gel 1-2 kb 999.00 522.86
RSII-random-ampliﬁed-1, 4, 8 h,-Manual Gel 2-3 kb 1173.00 1725.91
RSII-PolyA-non ampliﬁed-1 h (1st) 1077.00 323.67
RSII-PolyA-non ampliﬁed-1 h (2nd) 1403.00 625.65
RSII-PolyA-non ampliﬁed-2 h (1st) 1227.00 428.39
RSII-PolyA-non ampliﬁed-2 h (2nd) 1331.00 608.73
RSII-PolyA-non ampliﬁed-4 h (1st) 1207.00 529.63
RSII-PolyA-non ampliﬁed-4 h (2nd) 1307.00 585.04
RSII-PolyA-non ampliﬁed-6 h (1st) 1189.00 485.97
RSII-PolyA-non ampliﬁed-6 h (2nd) 1211.00 473.44
RSII-PolyA-non ampliﬁed-8 h (1st) 1120.00 443.99
RSII-PolyA-non ampliﬁed-8 h (2nd) 1390.00 554.59
RSII-PolyA-non ampliﬁed-12 h (1st) 1081.00 410.88
RSII-PolyA-non ampliﬁed-12 h (2nd) 1336.00 555.02
Table 2. Summary of the obtained read lengths from long-read sequencing. aType of the samples.
bAverage read lengths of the different library preparation and long-read sequencing approaches. cStandard
deviation (SD) values.
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cDNA synthesis, library preparation and sequencing Illumina sequencing
Total RNA was puriﬁed from PK-15 cells in various stages of PRV infection from 1 to 24 h pi and then,
the samples were mixed together to uncover an extensive variety of viral transcripts. Libraries were
prepared from ribo-depleted samples using the ScriptSeq v2 RNA-Seq Library Preparation Kit
(Epicentre/Illumina) according to the manufacturer’s recommendations. The kit uses a random-primed
(random hexamer with tagging sequence) cDNA synthesis reaction; this “original” protocol was used to
construct a paired-end library, but for PolyA sequencing (PA-seq), a single-end library was prepared
through the use of custom anchored adaptor-primer oligonucleotides with an oligo(VN)T20 primer
sequence (Table 5). Brieﬂy, the rRNA-depleted RNA samples were mixed with the primer (random or
oligo(d)T) and the RNA Fragmentation Solution (part of the ScriptSeq Kit), and the mixtures were
Sample No Sample Sample time points (h pi) RT priming Cap-selection Ampliﬁcation Size selection Library prep Platform
1 Mixed 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24 Oligo(d)T no yes no Illumina single-end HiScan SQ
2 Mixed 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24 Random no yes no Illumina paired-end HiScan SQ
3 1 h 1 Oligo(d)T no yes no PacBio Isoform seq RSII
4 4 h 4 Oligo(d)T no yes no PacBio Isoform seq RSII
5 8 h 8 Oligo(d)T no yes no PacBio Isoform seq RSII
6 Mixed 1, 2, 4, 6, 8 Oligo(d)T no yes Bluepippin 5kb+ PacBio Isoform seq RSII
7 Mixed 1, 2, 4, 6, 8 Oligo(d)T no yes Bluepippin 0.8-2kb PacBio Isoform seq RSII
8 Mixed 1, 2, 4, 6, 8 Oligo(d)T no yes Bluepippin 2-3kb PacBio Isoform seq RSII
9 Mixed 1, 2, 4, 6, 8 Oligo(d)T no yes Bluepippin 3-5kb PacBio Isoform seq RSII
10 Mixed 1, 2, 4, 6, 8 Oligo(d)T no yes Bluepippin 5kb+ PacBio Isoform seq RSII
11 Mixed 1, 4, 8 Oligo(d)T no yes Manual Gel 1-2kb PacBio Isoform seq RSII
12 1 h 1 Oligo(d)T no yes Manual Gel 3kb+ PacBio Isoform seq RSII
13 1 h 1 Oligo(d)T no yes Manual Gel 2-3kb PacBio Isoform seq RSII
14 4 h 4 Oligo(d)T no yes Manual Gel 3kb+ PacBio Isoform seq RSII
15 4 h 4 Oligo(d)T no yes Manual Gel 2-3kb PacBio Isoform seq RSII
16 8 h 8 Oligo(d)T no yes Manual Gel 3kb+ PacBio Isoform seq RSII
17 8 h 8 Oligo(d)T no yes Manual Gel 2-3kb PacBio Isoform seq RSII
18 Mixed 1, 2, 4, 6, 8 Random no yes no PacBio Isoform seq RSII
19 1 h 1 Random no yes no PacBio Isoform seq RSII
20 4 h 4 Random no yes no PacBio Isoform seq RSII
21 8 h 8 Random no yes no PacBio Isoform seq RSII
22 Mixed 1, 4, 8 Random no yes Manual Gel 3kb+ PacBio Isoform seq RSII
23 Mixed 1, 4, 8 Random no yes Manual Gel 1-2kb PacBio Isoform seq RSII
24 Mixed 1, 4, 8 Random no yes Manual Gel 2-3kb PacBio Isoform seq RSII
25 1 h 1 Oligo(d)T no no no PacBio 2kb RSII
26 1 h 1 Oligo(d)T no no no PacBio Very Low Input RSII
27 2 h 2 Oligo(d)T no no no PacBio 2kb RSII
28 2 h 2 Oligo(d)T no no no PacBio Very Low Input RSII
29 4 h 4 Oligo(d)T no no no PacBio 2kb RSII
30 4 h 4 Oligo(d)T no no no PacBio Very Low Input RSII
31 6 h 6 Oligo(d)T no no no PacBio 2kb RSII
32 6 h 6 Oligo(d)T no no no PacBio Very Low Input RSII
33 8 h 8 Oligo(d)T no no no PacBio 2kb RSII
34 8 h 8 Oligo(d)T no no no PacBio Very Low Input RSII
35 12 h 12 Oligo(d)T no no no PacBio 2kb RSII
36 12 h 12 Oligo(d)T no no no PacBio Very Low Input RSII
37 Mixed 1, 2, 4, 6, 8 Oligo(d)T no yes no PacBio Isoform seq Sequel
38 Mixed 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 18, 24 Oligo(d)T no no no ONT Direct RNA MinION
39 Mixed 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 18, 24 Oligo(d)T yes yes no ONT cDNA MinION
40 Mixed 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 18, 24 Oligo(d)T no yes no ONT cDNA MinION
Table 3. Summary table of the various wet lab approaches used in this study.
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incubated at 85 °C for 5 min. The following kit components were mixed together: cDNA Synthesis
Premix, DTT and StarScript AMV Reverse Transcriptase. This reagent mix was added to the pre-heated
RNA-mixtures and they were incubated at 25 °C for 5 min and then 42 °C for 20 min. Reactions were
cooled down to 37 °C. Finishing solution was added to the samples and incubation was continued at 37 °
C for an additional 10 min, then at 95 °C for 3 min. Samples were cooled down to 25 °C, and Terminal
Tagging Premix, as well as DNA Polymerase were added. The incubation was continued at 25 °C for 15
min and then at 95 °C for 3 min. The di-tagged cDNA samples were puriﬁed by using the AMPure XP
beads (Beckman Coulter). The puriﬁed samples were ampliﬁed by PCR using the FailSafe PCR Premix E,
primers and FailSafe PCR enzyme (Lucigen, Epicentre). The PCR conditions were as follows: initial
denaturation at 95 °C for 1 min, followed by 15 cycles at 95 °C for 30 sec 55 °C for 30 sec and 68 °C for 3
min. The ﬁnal incubation step was carried out at 68 °C for 7 min. The PCR amplicons were puriﬁed with
AMPure beads. The quantity and the quality of the samples were checked using Qubit ﬂuorometer (Life
Technologies) and Agilent 2100 Bioanalyzer, respectively.
PacBio SMRTbell library preparation & sequencing – the non-ampliﬁed method & RSII
sequencing
Generation of cDNAs. The SuperScript Double-Stranded cDNA Synthesis Kit (Life Technologies) was
used to prepare cDNAs from the polyA(+) RNA samples. These samples were used to quantify the PRV
transcriptome during the infection period between 1-12 h. The enzyme-which was included in the kit-was
changed to SuperScript III Reverse Transcriptase. The ﬁrst-strand synthesis reactions were primed with
Anchored Oligo(dT)20 primers (Life Technologies, Table 5). The obtained cDNAs were measured by
using Qubit HS dsDNA Assay Kit (Life Technologies). The total amount of cDNA synthesized at each
time point was used to prepare SMRTbell templates.
Preparation of SMRTbell libraries-“Barcoding method”
The cDNA samples (~500 ng/sample) were used to prepare SMRTbell templates by using the PacBio
DNA Template Prep Kit 1.0 following the Paciﬁc Biosciences’ 2 kb Template Preparation and Sequencing
protocol.
Repairing the cDNA ends. Template Prep Buffer, ATP High, dNTP and End Repair Mix (PacBio)
were added to the samples and then they were incubated at 25 °C for 15 min.
Sample puriﬁcation 0.6x volume. AMPure PB bead was added to the samples. They were mixed using
VWR vortex mixer for 10 min at 2000 rpm and room temperature. Tubes were placed in a magnetic bead
rack for 3 min. After the bead pellets were formed, the supernatant were discarded. Beads were 2-times
washed with freshly prepared ethanol (70%). Samples were dried and then they were eluted in 30 μl
Elution Buffer (PacBio).
Adapter ligation. This step was carried out at 25 °C for 15 min with the addition of speciﬁc bar-coded
adapters (Table 6), Template Prep Buffer, ATP Low and Ligase (PacBio). The enzyme was inactivated at
65 °C (10 min).
Total RNA isolation PolyA selection Ribodepletion Reverse transcription & dscDNA
production
cDNA synthesis by
PCR
Library preparation kit Sequencing
chemistry
Instrument
Macherey-Nagel
RNA
Qiagen Oligotex mRNA mini Kit –
StarScript AMV Reverse Transcriptase FailSafe PCR
PreMix Selection Kit
ScriptSeq v2 RNA-Seq
Library Preparation Kit
NA HiScan 2500– Epicentre Ribo-Zero™
Magnetic Kit H/M/R
Qiagen Oligotex mRNA mini Kit –
SuperScript III & SuperScript
double-stranded cDNA Synthesis Kit
–
PacBio Template
Preparation Kit
P5-C3
RSII
Clontech SMARTer PCR
cDNA Synthesis Kit
KAPA HiFi PCR Kit P6-C4– Epicentre Ribo-Zero™
Magnetic Kit H/M/R
Qiagen Oligotex mRNA mini Kit –
Sequel
SuperScript III – Direct RNA
Sequencing Kit
NA
MinIONSuperScript IV KAPA HiFi PCR Kit Ligation Sequencing
Kit 1D
NA
Lexogen Teloprime Kit
enzymes & reagents
Lexogen Teloprime
PCR mix
Ligation Sequencing
Kit 1D
NA
Table 4. Summary table of the reagents and chemistries used for the sequencing.
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Exonuclease treatment. ExoIII (50U) and ExoVII (5U) enzymes were added to the carrier DNA-
cDNA mixture, then they were incubated at 37 °C for 1 h, then the reactions were returned to 4 °C.
Sample puriﬁcation. SMRTbell Templates were puriﬁed using 0.6 × AMPure PB beads, as was
described above. Two puriﬁcation steps were applied after one other. The ﬁnal elution volume was 10 μl.
Qubit ﬂuorometer was used for quantitation.
SMRTbell templates were bound to the PacBio’s P5 DNA polymerase. These complexes were bound to
MagBeads using the Paciﬁc Biosciences MagBead Binding Kit. The concentrations of the SMRTbell
libraries were measured by Qubit and they were also qualiﬁed by Agilent 2100 Bioanalyzer. The PacBio
RSII platform and C3 sequencing chemistry was used for sequencing. 180 min movies were applied for
each SMRT Cell.
Annealing of the sequencing primers to the template DNA and the DNA polymerase
binding. The PacBio Calculator v.2.3.0.0. was used to set the annealing and binding reactions. 2000
bp insert size and 1 ng/μl concentration was set. The Sequencing Primer (5000 nM) was diluted to 150
nM with the PacBio Elution Buffer (EB). One μl from the diluted primer and 10x Primer Buffer were
added to the template DNA. Annealing was carried out at 80 °C for 2 min, and then the temperature was
ramp to 25 °C at a rate of 0.1 °C/sec. The total volume of annealed template was bound to the Polymerase.
For this, 2 μl dNTP, 2 μl DTT, 2 μl Binding Buffer (BB) and 2 μl diluted Polymerase were added to the
samples. Mixtures were incubated at 30 °C for 4 h and then they were heated to 37 °C for 30 min. 2 μl
from the complexes were used for MagBead binding. Cleaned MagBeads (74 μl) were added to the
samples and they were incubated at 4 °C for 2 h on a HulaMixer rotator (Invitrogen). After the
incubation, samples were washed with 19 μl BB, then 19 μl Wash Buffer (WB), and ﬁnally they were
resuspended in 19 μl BB. The total amount of the MagBead-bound complex was loaded onto the RSII
sequencer.
Preparation of SMRTbell libraries-“Carrier DNA method”
The total amount of cDNA synthesized at each time point was used to prepare SMRTbell templates by
using the PacBio DNA Template Prep Kit 1.0 and following the Paciﬁc Biosciences template preparation
and sequencing. protocol for Very Low (10 ng) Input 2 kb libraries with carrier DNA (pBR322, Thermo
Scientiﬁc).
Preparing the carrier DNA. The concentration of the pBR322 plasmid DNA was measured by
Nanodrop. A 100ng/μl stock solution was prepared from the plasmid using the PacBio Elution Buffer
(EB). The DNA was exonuclease treated with the PacBio ExoIII (200U) and ExoVII (20U) enzymes and
the Template Prep buffer (10 × ). The mixture was incubated at 37 °C for 1 h, then it was cooled down to
4 °C. The DNA was puriﬁed and concentrated by using 0.6 × AMPure® PB beads and it was eluted in 50
μL EB. The exonuclease-treated carrier DNA was quantiﬁed by Qubit ﬂuorometer.
Repairing the DNA damage. cDNA samples were mixed with DNA Damage Repair Buffer, NAD+,
ATP High, dNTP and DNA Damage Repair Mix (all from the PacBio DNA Template Prep Kit), and then
were incubated at 37 °C for 20 min. Samples were cooled to 4 °C.
Repairing the cDNA ends. End Repair Mix (PacBio) was added to the samples and then they were
incubated at 25 °C for 5 min.
Sample puriﬁcation 0.6x volume. AMPure PB bead was added to the samples and they were puriﬁed
as in case of the barcoded samples.
Adapter ligation. This step was carried out at 25 °C for 60 min with the addition of Blunt Adapter,
Template Prep Buffer, ATP Low and Ligase (PacBio). The enzyme was inactivated at 65 °C (10 min).
After this step, the ExoIII and ExoVII-treated carrier DNA (5 μl; 100 ng/μl) was mixed with the
adapter-ligated cDNA samples (40 μl).
Exonuclease treatment. ExoIII (50U) and ExoVII (5U) enzymes were added to the carrier DNA-
cDNA mixture, then they were incubated at 37 °C for 1 hour, then the reactions were returned to 4 °C.
Sample puriﬁcation. Two puriﬁcation steps were carried out successively, as was described earlier.
SMRTbell libraries were bound to DNA polymerases by using the DNA polymerase binding kit P5 and
v2 sequencing primers. The DNA polymerase/template complexes were bound to MagBeads using the
MagBead Binding Kit. The concentrations of the SMRTbell libraries were measured by Qubit and they
were further analysed by Agilent 2100 Bioanalyzer. The cDNA sequencing reactions were carried out on
the PacBio RSII platform with C3 sequencing chemistry with 180 min movies.
Annealing of the sequencing primers to the template DNA and the DNA polymerase
binding. Conditioning and annealing of the Sequencing Primer, the binding of the Polymerase to
the libraries, as well as Polymerase-template complex binding to the magnetic beads was done exactly as
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indicated by the PacBio Very Low Input protocol. The total amounts of prepared libraries (10 μl) were
used for the binding. The DNA concentrations were set to 0.1 μl in the Calculator version 2.3.0.0. The
“small-scale” preparation protocol and the “non-standard” protocol were chosen. The Sequencing Primer
(5000 nM) was diluted to 150 nM in EB. One μl from the diluted primer and 10x Primer Buffer were
added to the template DNA. Annealing was carried out at 80 °C for 2 min then the temperature was ramp
to 25 °C at a rate of 0.1 °C/sec. The total volume of annealed template was bound to the Polymerase. For
this, 2 μl dNTP, 2 μl DTT, 2 μl BB and 2 μl diluted Polymerase were added to the samples. Mixtures were
incubated at 30 °C for 4 h and then they were heated to 37 °C for 30 min. The total volume from the
polymerase binding step was used for MagBead binding. The salt molarity was adjusted for optimal
binding by adding WB (0.3 × volume) to the bound complex instead of BB. Cleaned MagBeads (26 μl)
were added to the samples and they were incubated at 4 °C for 30 min on a HulaMixer rotator
(Invitrogen). After the incubation, samples were washed with 26 μl BB, then 26 μl BW, and ﬁnally they
were resuspended in 19 μl BB. The total amount of the MagBead-bound complex was loaded onto the
PacBio machine.
PacBio SMRTbell library preparation-Iso-Seq method/the ampliﬁed protocol & sequencing
on RSII as well as Sequel platforms
Full-length cDNAs were generated using the Clontech SMARTer PCR cDNA Synthesis Kit based on the
PacBio Isoform Sequencing (Iso-Seq) protocol. No Size Selection method was carried out for the analysis
of short viral transcripts, while Manual Agarose-gel Size Selection, as well as SageELF™ and BluePippin™
Size-Selection Systems (Sage Science) were used for the isolation of long RNA molecules. The ﬁrst-strand
cDNAs were generated by using the SMARTer PCR cDNA Synthesis Kit (Clontech), the reactions were
primed with oligo(dT) (part of the Clontech Kit) or adapter-linked GC-rich random primers (ordered
from IDT DNA). The single-stranded cDNAs were PCR-ampliﬁed using KAPA HiFi Enzyme (Kapa
Biosystems), in accordance with recommendations provided by PacBio, as follows: initial denaturation
was carried at −95 °C for 2 min, followed by 16 cycles for PA-seq, 20 or 30 cycles for random-primed
samples (the optimal cycle was determined in the optimization step) at −98 °C for 20 s (denaturation),
−65 °C for 15 s (annealing) −72 °C for 4 min (extension). The ﬁnal extension was carried out at −72 °C for
5 min. (n: 16 cycles was ideal for the No size-selection protocol. For the agarose size-selection, 12 cycles
and 1:45 min extension was set for the ampliﬁcation of transcripts between 2–3 kb and 15 cycles and 3
min extension was used for the longer transcripts. Sixteen cycles were set for the SageELF and BluePippin
samples. PCR products were pooled then size selected manually by using 0.8% agarose gel or with the
SageELF™ System according to the PacBio's protocol. Size-selected samples were ampliﬁed with KAPA
enzyme using the conditions as above. The fraction of cDNAs with a size over 5 kb was run on
BluePippin™ System to eliminate the short SMRTbell libraries. Five-hundred ng of each non-size-selected
cDNA sample was applied for the SMRTbell template preparation, using the PacBio DNA Template Prep
Kit 1.0. The amount of cDNAs from the size-selected samples used in the library preparation reaction
were based on the following PacBio protocols: Procedure & Checklist – Isoform Sequencing (Iso-Seq™)
using the Clontech SMARTer PCR cDNA Synthesis Kit and (a) Manual Agarose-gel Size Selection; (b)
SageELF™ Size Selection System; and (c) BluePippin™ Size-Selection System. SMRTbell sequencing
libraries were bound to polymerases by using the DNA/Polymerase Binding Kit P6 and v2 primers. The
polymerase-template complexes were bound to MagBeads with the PacBio MagBead Binding Kit. The
qualities of the samples were checked on the Agilent 2100 Bioanalyzer. Sequencing reactions were
performed by using the PacBio RS II sequencer with DNA Sequencing Reagent 4.0. Movie lengths were
240 min or 360 min (one movie was recorded for each SMRT Cell).
Sequencing method Name, availability Catalog # Sequence (5' -> 3')
Illumina PolyA Custom made-adaptor-primer VN(T)20 (IDT DNA) - GTGTGCTCTTCCGATCT(T)20VN
Illumina random Random hexamer + tagging sequence-ScriptSeq™ v2
RNA-Seq Library Preparation Kit (Epicentre)
SSV21106 & SSV21124 GTGTGCTCTTCCGATCTNNNNNN
PacBio non-ampliﬁed Anchored Oligo(dT)20 primers (Life Technologies) 12577011 TTTTTTTTTTTTTTTTTTTTVN
PacBio ampliﬁed PolyA 3' SMART CDS primer II A-SMARTer PCR
cDNA Synthesis Kit (Clontech)
634925 & 634926 AAGCAGTGGTATCAACGCAGAGTAC(T)30VN
PacBio ampliﬁed Random Custome made (IDT DNA) - AAGCAGTGGTATCAACGCAGAGTACNNNNNN (G: 37%; C: 37%; A: 13%; T: 13%)
MinION cDNA Poly(T)-containing anchored primer
[(VN)T20-ONT recommended, custom made (Bio Basic)
- 5phos/ ACTTGCCTGTCGCTCTATCTTC(T)20VN
MinION CAP selected TeloPrime Full-Length cDNA
Ampliﬁcation Kit (Lexogen)
013.08 & 013.24 TCTCAGGCGTTTTTTTTTTTTTTTTTT
MInION RNA RT adapter-Direct RNA Sequencing Kit
(Oxford Nanopore Technologies)
SQK-RNA001 GAGGCGAGCGGTCAATTTTCCTAAGAGCAAGAAGAAGCCTTTTTTTTTT
Table 5. The list of primers used in this study for the reverse transcription reactions.
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The volume of the sequencing primer for the annealing, and the polymerase (P5 or P6) for the binding
was determined using the PacBio Calculator version 2.3.1.1., by adding the concentrations and the
average insert sizes of SMRTbell templates.
The polymerase-template complexes were bound to MagBeads, loaded onto SMRT Cells and
sequenced on the RSII instrument.
The PacBio’s Binding Calculator was used to prepare the library for sequencing using the MagBead
one-cell per well (OCPW) protocol, and binding kit P6v2 was used with an on-plate concentration of
0.05 nM. The insert sizes were set according to the size-selections which were applied: 1000, 2500 and
6000 bp sizes were chosen.
In short, the sequencing primer was diluted in PacBio EB to 150 nM. The annealing step was
performed with 1 μl template DNA (cc: ~20 ng/μl), the diluted sequencing primer and primer buffer
(10x). The ﬁnal concentration of this mixture was 0.8333 nM. Annealing was carried out at 20 °C for 30
min then the DNA polymerase enzyme was diluted to a ﬁnal concentration of 50 nM in PacBio BB v2,
and then it was bound to the annealed template followed by the addition of DTT, dNTP and BB. The
complex (0.5 nM ﬁnal concentration) was incubated at 30 °C for 4 h. The sample complex (0.5 μl) was
mixed with and 18.5 μl MagBead Binding Buffer (0.0125 nM ﬁnal concentration). MagBeads were
prepared as follows: 73.9 μl MagBeads were washed with 73.9 μl MagBead WB, then 73.9 μl MagBead BB
was added. The sample complex was bound to the washed, prepared MagBeads for loading to the RSII
machine: 19 μl sample complex was added to the beads, and then it was placed at 4 °C for 30 min in a
HulaMixer. After incubation, the MagBead-bound complex was washed with 19 μl BB, then with 19 μl
WB and ﬁnally, it was resuspended in 19 μl BB. The total amount of the MagBead-bound complex was
loaded onto the instrument. The MagBead One Cell Per Well protocol was used. One SMRT Cell was also
run on Sequel instrument.
Oxford Nanopore cDNA sequencing. PRV transcripts were sequenced on MinION device using the
1D Strand switching cDNA by ligation method (Version: SSE_9011_v108_revS_18Oct2016) and the
ONT Ligation Sequencing Kit 1D (SQK-LSK108). For this, PolyA(+)-selected RNAs were used. 50ng
from the samples were subjected to reverse transcription. Poly(T)-containing anchored primer [(VN)T20;
ordered from Bio Basic, Canada, (Table 5)] and dNTPs (10 mM, Thermo Scientiﬁc) was added to the
RNA samples and then the mixture was incubated at 65 °C for 5 min. Buffer and DTT from SuperScipt
IV Reverse Transcriptase kit (Life Technologies), RNase OUT (Life Technologies) and strand-switching
oligo with three O-methyl-guanine RNA bases (PCR_Sw_mod_3G; ordered from Bio Basic, Canada)
were added and the sample was incubated at 42 °C for 2 min. 200U SuperScript IV Reverse Transcriptase
enzyme was measured into the mix. First-strand cDNA synthesis was carried out at 50 °C for 10 min; it
was followed by the strand switching step at 42 °C for 10 min. Enzymes were inactivated at 80 °C for 10
min. Five μl from the prepared double-stranded cDNA was ampliﬁed in a single PCR reaction using
KAPA HiFi DNA Polymerase (Kapa Biosystems) and Ligation Sequencing Kit Primer Mix (provided by
the 1D Kit). The Veriti Thermal Cycler (Applied Biosystems) was set as the 1D Kit’s protocol
recommended: initial denaturation for 30 sec at 95 °C (1 cycle); denaturation for 15 sec at 95 °C (15
cycles); annealing for 15 sec at 62 °C (15 cycles); elongation for 4 min at 65 °C (15cycles); ﬁnal extension
10 min at 65 °C. NEBNext End repair / dA-tailing Module (New England Biolabs) was used for end
repair, while NEB Blunt/TA Ligase Master Mix (New England Biolabs) was applied for adapter ligations.
The adapter sequences were supplied by the kit. Agencourt AMPure XP magnetic beads (Beckman
Coulter) were used for puriﬁcation following each enzymatic step. The Qubit Fluorometer (Life
Technologies Qubit 2.0) and the Qubit (ds)DNA HS Assay Kit were used to quantify the concentration of
the libraries. Samples were loaded on R9.4 SpotON Flow Cells, and base calling was performed using
Albacore v1.2.6.
Oxford Nanopore sequencing on Cap-selected samples. To obtain full-length transcripts with the
exact 5′-ends, Cap selection was carried out. For this, the TeloPrime Full-Length cDNA Ampliﬁcation Kit
(Lexogen) was used, which has an exceptional speciﬁcity for 5′-Cap. The starting material was 2 μg total
Name Sequence
PBBC adapter #1 [Phos]TATGCTAATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGATTAGCATA
PBBC adapter #2 [Phos]GACAGTGATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGATCACTGTC
PBBC adapter #3 [Phos]GATCTCGATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGATCGAGATC
PBBC adapter #4 [Phos]TACACGTATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGATACGTGTA
PBBC adapter #5 [Phos]GAGCTCAATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGATTGAGCTC
PBBC adapter #6 [Phos]TCTGCAGATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGATCTGCAGA
Table 6. Barcode sequences utilized for PacBio sequencing. This table contains the modiﬁed adapter
sequences with unique barcodes which were used for multiplex sequencing. The barcode sequences are labelled
by blue colour.
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RNA diluted in 12 μl water, from a mixed PRV sample (containing RNA from 1, 2, 3, 4, 5, 6, 7, 8, 12, 18
and 24 h post-infection). The method based on cDNA generation. Reverse transcription (RT) was carried
out according to the kit’s manual. Brieﬂy, the diluted RNA was mixed with RT buffer, primer (both are
supplied by the kit). The RT primer contains an “oligodT” sequence (Table 5) to select the polyadenylated
transcripts. The mixture was preheated at 70 °C for 30 sec, then it was cooled down to 37 °C for 1 min. RT
enzyme and reagents (part of the kit) were added and the reaction was contain at 37 °C for 2 min.
Temperature was increased to 46 °C for 50 min. The RNA-cDNA hybrid was puriﬁed using silica
columns (kit’s component). A speciﬁc adapter was ligated to the cDNA by base-pairing of the 5’C to the
cap structure of the RNA. This step was carried out by the double-strand speciﬁc ligase of the kit. Ligation
was performed at 25 °C, overnight. The sample was puriﬁed after ligation using the silica columns. The
cDNA was converted to dscDNA using the Second-Strand Mix and the Enzyme Mix from the Teloprime
kit. The reaction was carried out in a Veriti Cycler with the following protocol: 98 °C for 90 sec, 62 °C for
60 sec, 72 °C for 5 min, hold at 25 °C.
Sample concentration was measured using Qubit dsDNA HS Assay Kit (Life Technologies). Speciﬁcity
of the obtained cDNA was checked by qPCR (Rotor-Gene Q) using a gene speciﬁc primer (us9, 10μM
each; Table 7), cDNA and ABsolute qPCR SYBR Green Mix (Thermo Fisher Scientiﬁc) in 20 μl ﬁnal
volume. The initial denaturation was 94 °C 15 min, and it was followed by 35 cycles of 94 °C for 25 sec,
60 °C 25 sec and 72 °C 6 sec.
The PolyA(+)-CAP-selected samples were also sequenced on MinION using the 1D Strand switching
cDNA by ligation method. These samples were subjected to the end repair and adapter ligation steps, and
then they were loaded on the ONT Flow Cells.
Oxford Nanopore direct RNA sequencing. Three ﬂow cells were used for sequencing PRV samples
following the Direct RNA sequencing (DRS) protocol from the ONT (Version: DRS_9026_v1_revM_15-
Dec2016). Total RNAs from 12 different time points were mixed together, and then polyA selection was
carried out. RNA from the PolyA(+) fraction in 9 μl was used as a template for sequencing. RNA was
mixed with the RT (oligodT-containing T10) adapter (supplied by the ONT Direct RNA Sequencing Kit;
SQK-RNA001; Oxford Nanopore Technologies) and T4 DNA ligase (2M U/ml; New England BioLabs).
The mixture was incubated at room temperature for 10 min. First-strand cDNA synthesis was carried out
in 40 μl ﬁnal volume with SuperScript III Reverse Transcriptase (Life Technologies), according to the
DRS protocol, at 50 °C for 50 min, then 70 °C for 10 min in a Veriti Thermal Cycler. Samples were
washed with Agencourt AMPure XP Beads (Beckman Coulter). XP Beads were treated before usage with
RNase OUT (40 U/μl; Life Technologies); 2U enzyme was added to 1 μl bead. Puriﬁed RNA-cDNA
hybrids were eluted in 20 μl Ambion Nuclease-Free Water (Thermo Fisher Scientiﬁc). RMX sequencing
adapter was ligated to the eluted samples with T4 DNA ligase and NEBNext Quick Ligation Reaction
Buffer (New England BiceoLabs) at room temperature for 10 min. Samples were puriﬁed with RNase
OUT-treated XP beads using Wash Buffer (part of the DRS Kit) and then eluted in 21 μl Elution Buffer
(provided by the DRS Kit). The concentration of the reverse-transcribed and adapted RNA was measured
by using the Qubit 2.0 Fluorometer and Qubit dsDNA HS Assay Kit (Life Technologies). Samples were
loaded onto the R9.4 SpotON Flow Cell.
Data on the quality of PacBio RSII, Sequel, and ONT MinION reads including insertions, deletions,
and mismatches, as well as the coverages are summarized in Table 8 (available online only).
Read processing
Raw reads from the random-primed Illumina sequencing were aligned to the PRV genome (KJ717942.1),
using Tophat v2.09 (ref. 23); ambiguous reads were discarded. For PA-Seq, mapping was carried out with
Bowtie v2 (ref. 24).
The PacBio RSII and Sequel consensus reads were generated following the RS_ReadsOfInsert protocol
of the SMRT Analysis (v2.3.0 and v5.0.0) (Fig. 2), with the following settings: Minimum Full Passes= 1,
Minimum Predicted Accuracy= 90, Minimum Length of Reads of Insert= 1, Maximum Length of Reads
of Insert=No Limit. These consensus reads were mapped using GMAP25, with the following settings:
gmap -d Genome.fa --nofails -f samse File.fastq>Mapped_ﬁle.sam.
The ONT's Albacore software (v.2. 0.1) was used for base calling. This basecaller identify the
nucleotide sequences directly from raw data. The sequencing reads were mapped with GMAP using the
same setting as was described above.
Custom routines were used to acquire the quality information presented in this data descriptor. The
codes have been archived on Github (https://doi.org/10.5281/zenodo.1034511).
Primer Sequence
Forward CAGGACGACTCGGACTGCTA
Reverse AGGAACTCGCTGGGCGT
Table 7. The gene-speciﬁc primers used for the ampliﬁcation of us9 gene of PRV.
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Data Records
All sequencing data have been uploaded to the European Nucleotide Archive under the project accession
PRJEB24593 (Data Citation 1)-contains BAM ﬁles-and PRJEB9526 (Data Citation 2) – containing
FASTQ ﬁles -. All sequencing reads were mapped to the KJ717942.1 genome build. All data can be used
without restrictions.
Technical Validation
The quantity of the isolated total RNAs, the polyA-selected RNAs, the rRNA-depleted samples, as well as
the synthesized cDNA fractions and sequencing-ready libraries were measured by Qubit 2.0 (Life
Technologies) ﬂuorometer using the Qubit RNA, HS RNA and HS dsDNA Assay Kits. The conditions for
primer annealing and binding of the polymerase to the templates were determined by PacBio’s Binding
Calculator in RS Remote. The libraries were measured by Agilent 2100 Bioanalyzer using the Agilent
High Sensitivity DNA Kit.
Usage Notes
The provided dataset was primarily produced to discover and determine the complexity and expression
dynamic properties of PRV transcriptome. The uploaded binary alignment (BAM) ﬁles contain reads
already mapped to the KJ717942.1 reference. These aligned ﬁles can be further analysed using various
bioinformatics program packages, such as bedtools26, samtools27, or visualized using e.g. IGV28,
Geneious29 or Artemis30. The uploaded Illumina, PacBio and ONT ﬁles have not been trimmed, they
contain terminal poly(A) sequences as well as the 5′and 3′ adapter sequences, which can be used to
determine the orientations of the reads.
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